Auckland DHB

HealthITAnalytics | February 19, 2020

Using artificial intelligence, EKGs may soon be able to screen for hypertrophic cardiomyopathy, an underdiagnosed condition that interferes with the heart’s ability to function properly. With hypertrophic cardiomyopathy, the heart’s walls thicken and make it harder for the heart to pump blood. The disease also predisposes some patients to potentially fatal abnormal rhythms. Hypertrophic cardiomyopathy often doesn’t cause symptoms, and patients are often unaware they have it unt...

DrFirst | July 24, 2020

For years, payers and healthcare providers have struggled to exchange patients' up-to-the-minute medical histories and insurance coverage details within electronic health record (EHR) workflows at the point of care. DrFirst, a pioneer in technology, support, and services that connect people at touchpoints of patient care, is introducing CareComplete to bridge these gaps. CareComplete responds to physicians' calls for tools that eliminate information silos and reduce healthcare delivery c...

HEALTH TECHNOLOGY

Clearbridge Mobile | November 04, 2020

Clearbridge Mobile is glad to have assumed an essential function in helping the Cardiac Arrhythmia Network of Canada (CANet) dispatch, VIRTUES, an online electronic application created to decrease crisis division visits and improve COVID-19 patient-driven consideration. With a considerable lot of Canada's telehealth arrangements under gigantic strain because of the pandemic, the requirement for an advanced arrangeme...

HEALTH TECHNOLOGY

Texas Children Hospital | December 29, 2021

Texas Children's Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General ofIndia(DCGI)to launch inIndiawith other underserved countries to follow. Dubbed "The World's COVID-19 Vaccine", it uses a tradi...